Literature DB >> 19779487

Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device.

Stacey S Hickson1, Mark Butlin, Jeremy Broad, Alberto P Avolio, Ian B Wilkinson, Carmel M McEniery.   

Abstract

Aortic stiffness, an independent predictor of cardiovascular risk and all-cause mortality, can be estimated non-invasively by measuring carotid to femoral (aortic) pulse wave velocity (aPWV). The Vicorder device has been developed to measure aPWV with little operator training in a non-intrusive manner. The aim of this study was to assess the repeatability of aPWV measured with the Vicorder device and to compare aPWV values with those obtained using the SphygmoCor system. Vicorder and SphygmoCor aPWV was assessed in 122 subjects (53+/-18 years, 46 male) using both the manufacturers' and a standardized approach. Vicorder aPWV measurement proved to be highly repeatable (within-subject coefficient of variation 2.8%). Transit time differed significantly between the two devices (mean difference 22+/-9 ms, P<0.001), independent of the different algorithms used to calculate transit time. However, aPWV was similar between the two devices (mean difference 0.31+/-1.54 m s(-1), P<0.001) though with an inherent bias toward lower Vicorder aPWV values at high values of SphygmoCor aPWV. Bias was reduced by subtracting the additional femoral artery segment measured by the Vicorder device, also bringing the measure of transit time in closer agreement to SphygmoCor values (mean difference 5+/-9 ms, P<0.001). Transit time values significantly differed between the two devices and the Vicorder device reported lower aPWV values at higher SphygmoCor values of aPWV. This difference in transit time and inherent bias was reduced when adjustment for the additional femoral artery segment measured by the Vicorder device was made.

Mesh:

Year:  2009        PMID: 19779487     DOI: 10.1038/hr.2009.154

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  62 in total

1.  Association between self-reported snoring and arterial stiffness: data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Martino Morbini; Riccardo Urso; Martina Rosticci; Angelo Parini; Elisa Grandi; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2015-09-28       Impact factor: 3.397

2.  Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.

Authors:  Natasha J McIntyre; Richard J Fluck; Christopher W McIntyre; Maarten W Taal
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

3.  Oscillometric assessment of arterial stiffness in everyday clinical practice.

Authors:  Alexander Reshetnik; Christopher Gohlisch; Markus Tölle; Walter Zidek; Markus Van Der Giet
Journal:  Hypertens Res       Date:  2016-09-08       Impact factor: 3.872

Review 4.  Uses of Arterial Stiffness in Clinical Practice.

Authors:  Ian B Wilkinson; Kaisa M Mäki-Petäjä; Gary F Mitchell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-27       Impact factor: 8.311

5.  Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus.

Authors:  Nur Canpolat; Ozgur Kasapcopur; Salim Caliskan; Selman Gokalp; Meltem Bor; Mehmet Tasdemir; Lale Sever; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2012-10-10       Impact factor: 3.714

6.  High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individuals.

Authors:  Iolanda Riba-Llena; Cristina Nafría; Josefina Filomena; José L Tovar; Ernest Vinyoles; Xavier Mundet; Carmen I Jarca; Andrea Vilar-Bergua; Joan Montaner; Pilar Delgado
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

7.  Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study.

Authors:  Arrigo Francesco Giuseppe Cicero; Martina Rosticci; Angelo Parini; Cristina Baronio; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2013-11-09       Impact factor: 3.397

8.  Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT.

Authors:  Sharlene A Greenwood; Pelagia Koufaki; Jamie H Macdonald; Catherine Bulley; Sunil Bhandari; James O Burton; Indranil Dasgupta; Kenneth Farrington; Ian Ford; Philip A Kalra; Mick Kumwenda; Iain C Macdougall; Claudia-Martina Messow; Sandip Mitra; Chante Reid; Alice C Smith; Maarten W Taal; Peter C Thomson; David C Wheeler; Claire White; Magdi Yaqoob; Thomas H Mercer
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

9.  Cardiovascular alterations do exist in children with stage-2 chronic kidney disease.

Authors:  Mehmet Taşdemir; Ayşe Güler Eroğlu; Nur Canpolat; Dildar Konukoğlu; Ayşe Ağbaş; Meltem Dönmez Sevim; Salim Çalışkan; Lale Sever
Journal:  Clin Exp Nephrol       Date:  2016-01-28       Impact factor: 2.801

10.  Arteriosclerosis and arterial remodeling; different mechanisms in young adults.

Authors:  Antonios A Argyris; Dimitrios A Vrachatis; Theodore G Papaioannou
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.